D
HealthLynked Corp.
HLYK
$0.04
-$0.0004-0.99%
D
Sell
2/11/2025Upgraded
HealthLynked Corp. (HLYK) was upgraded to D- from E+ on 2/11/2025 due to an increase in the volatility index and valuation index.
HealthLynked Corp. (HLYK) was upgraded to D- from E+ on 2/11/2025 due to an increase in the volatility index and valuation index.
E
Sell
9/9/2024Downgrade
HealthLynked Corp. (HLYK) was downgraded to E+ from D- on 9/9/2024 due to a decline in the volatility index and total return index.
HealthLynked Corp. (HLYK) was downgraded to E+ from D- on 9/9/2024 due to a decline in the volatility index and total return index.
D
Sell
8/22/2024Upgraded
HealthLynked Corp. (HLYK) was upgraded to D- from E+ on 8/22/2024 due to an increase in the valuation index and total return index.
HealthLynked Corp. (HLYK) was upgraded to D- from E+ on 8/22/2024 due to an increase in the valuation index and total return index.
E
Sell
3/14/2023Downgrade
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 03/14/2023.
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index.
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 02/08/2023.
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 02/08/2023.
D
Sell
2/6/2023Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from D- on 2/6/2023 due to an increase in the volatility index and total return index.
HealthLynked Corp. (HLYK) was upgraded to D from D- on 2/6/2023 due to an increase in the volatility index and total return index.
D
Sell
1/20/2023Downgrade
HealthLynked Corp. (HLYK) was downgraded to D- from D on 1/20/2023 due to a decline in the valuation index and volatility index.
HealthLynked Corp. (HLYK) was downgraded to D- from D on 1/20/2023 due to a decline in the valuation index and volatility index.
D
Sell
1/5/2023Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from D- on 1/5/2023 due to an increase in the volatility index.
HealthLynked Corp. (HLYK) was upgraded to D from D- on 1/5/2023 due to an increase in the volatility index.
D
Sell
12/21/2022Downgrade
HealthLynked Corp. (HLYK) was downgraded to D- from D on 12/21/2022 due to a significant decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.18 to 0.3, and the quick ratio declined from 0.17 to 0.09.
HealthLynked Corp. (HLYK) was downgraded to D- from D on 12/21/2022 due to a significant decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.18 to 0.3, and the quick ratio declined from 0.17 to 0.09.
D
Sell
5/4/2022Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 05/04/2022.
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 04/21/2022.
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 437.86% from $634.2 to -$2.14M, earnings per share declined from -$0.002 to -$0.0101, and EBIT declined 220.27% from -$490.3 to -$1.57M.
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 437.86% from $634.2 to -$2.14M, earnings per share declined from -$0.002 to -$0.0101, and EBIT declined 220.27% from -$490.3 to -$1.57M.
D
Sell
11/9/2021Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 11/09/2021.
HealthLynked Corp. (HLYK) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 11/8/2021 due to a large decline in the growth index and valuation index. Total revenue declined 4.15% from $1.78M to $1.71M.
HealthLynked Corp. (HLYK) was downgraded to E+ from D on 11/8/2021 due to a large decline in the growth index and valuation index. Total revenue declined 4.15% from $1.78M to $1.71M.
D
Sell
5/15/2020Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from D- on 5/15/2020 due to a major increase in the growth index and volatility index. Earnings per share increased from -$0.0286 to -$0.01, EBIT increased 39.49% from -$871.9 to -$527.6, and operating cash flow increased 39.39% from -$633.9 to -$384.2.
HealthLynked Corp. (HLYK) was upgraded to D from D- on 5/15/2020 due to a major increase in the growth index and volatility index. Earnings per share increased from -$0.0286 to -$0.01, EBIT increased 39.49% from -$871.9 to -$527.6, and operating cash flow increased 39.39% from -$633.9 to -$384.2.
D
Sell
5/11/2020Downgrade
HealthLynked Corp. (HLYK) was downgraded to D- from D on 5/11/2020 due to a decline in the total return index and volatility index.
HealthLynked Corp. (HLYK) was downgraded to D- from D on 5/11/2020 due to a decline in the total return index and volatility index.
D
Sell
5/1/2020Downgrade
HealthLynked Corp. (HLYK) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index, solvency index and total return index.
HealthLynked Corp. (HLYK) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index, solvency index and total return index.
D
Sell
4/1/2020Upgraded
HealthLynked Corp. (HLYK) was upgraded to D+ from D on 4/1/2020 due to a significant increase in the efficiency index, total return index and valuation index.
HealthLynked Corp. (HLYK) was upgraded to D+ from D on 4/1/2020 due to a significant increase in the efficiency index, total return index and valuation index.
D
Sell
8/19/2019Downgrade
HealthLynked Corp. (HLYK) was downgraded to D from D+ on 8/19/2019 due to a significant decline in the efficiency index, total return index and valuation index.
HealthLynked Corp. (HLYK) was downgraded to D from D+ on 8/19/2019 due to a significant decline in the efficiency index, total return index and valuation index.
D
Sell
5/17/2019Downgrade
HealthLynked Corp. (HLYK) was downgraded to D+ from C- on 5/17/2019 due to a decline in the total return index and growth index. Operating cash flow declined 34.59% from -$446.1 to -$600.4, and total revenue declined 8.36% from $507.4 to $465.
HealthLynked Corp. (HLYK) was downgraded to D+ from C- on 5/17/2019 due to a decline in the total return index and growth index. Operating cash flow declined 34.59% from -$446.1 to -$600.4, and total revenue declined 8.36% from $507.4 to $465.
C
Hold
4/3/2019Upgraded
HealthLynked Corp. (HLYK) was upgraded to C- from D on 4/3/2019 due to a significant increase in the efficiency index, total return index and growth index. Earnings per share increased from -$0.03 to -$0.014, net income increased 46.16% from -$2.21M to -$1.19M, and operating cash flow increased 35.08% from -$687.2 to -$446.1.
HealthLynked Corp. (HLYK) was upgraded to C- from D on 4/3/2019 due to a significant increase in the efficiency index, total return index and growth index. Earnings per share increased from -$0.03 to -$0.014, net income increased 46.16% from -$2.21M to -$1.19M, and operating cash flow increased 35.08% from -$687.2 to -$446.1.
D
Sell
6/5/2018Upgraded
HealthLynked Corp. (HLYK) was upgraded to D from D- on 6/5/2018 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 13.06% from -$487.9 to -$424.2, and total revenue increased 2.49% from $629.9 to $645.6.
HealthLynked Corp. (HLYK) was upgraded to D from D- on 6/5/2018 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 13.06% from -$487.9 to -$424.2, and total revenue increased 2.49% from $629.9 to $645.6.
D
Sell
2/1/2018Upgraded
HealthLynked Corp (HLYK) was upgraded to D- from E on 2/1/2018 due to an increase in the valuation index.
HealthLynked Corp (HLYK) was upgraded to D- from E on 2/1/2018 due to an increase in the valuation index.
E
Sell
11/1/2017Upgraded
HealthLynked Corp (HLYK) was upgraded to E from E- on 11/1/2017 due to an increase in the solvency index, growth index and valuation index. Debt to equity declined from -0.86 to -0.94, and total revenue increased 8.55% from $476.1 to $516.8.
HealthLynked Corp (HLYK) was upgraded to E from E- on 11/1/2017 due to an increase in the solvency index, growth index and valuation index. Debt to equity declined from -0.86 to -0.94, and total revenue increased 8.55% from $476.1 to $516.8.
E
Sell
7/31/2017None
HealthLynked Corp. (HLYK) was downgraded to E- from U on 07/31/2017.
HealthLynked Corp. (HLYK) was downgraded to E- from U on 07/31/2017.
OTC PK
03/07/2025 3:56PM Eastern
Quotes delayed
